A monoclonal antibody against interleukin-12 and interleukin-23 has been approved by the FDA for the treatment of plaque psoriasis. Ustekinumab is marketed as a subcutaneous injection by Centocor Ortho Biotech as Stelara™.
The ECG shown above was obtained from a 60-year-old man with a history of a dilated cardiomyopathy. Given this information, what clinical concerns might you have if this patient presented to the emergency department in heart failure with the tracing above?
Congestive heart failure (CHF) is the most common DRG for Medicare patients in U.S. hospitals and is therefore the target of considerable regulatory attention due to its financial impact on the federal budget.
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions
Prostate cancer is the most common non-cutaneous cancer and is the second leading cause of cancer death for men in the United States.
